Pfizer (PFE)

Pfizer's price has risen above every major trend line it tracks, for the first time in months.

What is going on right now?

The stock has been climbing steadily and recently moved faster than usual. Streaks like this have often taken a breather, though nothing says when.

How is the business itself doing?

Pfizer's revenue grew about 2.6% recently, and it keeps roughly 75 cents of every dollar of sales before production costs. But it's paying out more in dividends than it earns right now, with a payout ratio around 226%.

What stands out?

The company barely moves with the broader market. Its sensitivity score is just 0.28, meaning a big market swing tends to nudge Pfizer only a little.

What comes next?

Pfizer's next earnings report lands on November 3, 2026, the first look at whether that revenue growth is picking up speed or flattening out.